Investors should certainly avoid these three Nasdaq stocks in trouble, and shorting them could turn out to be very profitable. More
Articles
Why Is Dermata Therapeutics (DRMA) Stock Up 23% Today?
Dermata Therapeutics (DRMA) stock is taking off on Friday despite a lack of news from the clinical-stage biotechnology company. More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday! More
Even at Under a Nickel, XELA Stock Isn’t Worth a Penny
Taking all factors into account, it's clear why I believe XELA stock today isn't worth even a penny. More
ALLY Stock: Ignore the Buffett Rumors, Stay Away
Following the bank sector sell-off, there may be some worthwhile bargains out there, but ALLY stock isn't one of them. Tune out the takeover talk, and steer clear. More